Adalimumab had superior efficacy and safety outcomes compared with secukinumab and bimekizumab for the treatment of hidradenitis suppurativa.

Celltrion, Inc. announced that the U.S. Food and Drug Administration granted an interchangeable designation to ...

If you are using this medication to treat psoriasis, hidradenitis suppurativa ... this to prevent a serious TB infection while using adalimumab. To lower the chance of getting cut, bruised ...

The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic ...

Most patients with hidradenitis suppurativa are dissatisfied with their treatment and do not know about all treatment options.

The Hidradenitis Suppurativa Genetics Consortium shares our findings on the genetic links between HS and inborn errors of ...

The US Food and Drug Administration (FDA) has designated Celltrion’s Yuflyma (adalimumab-aaty) as an interchangeable biosimilar to AbbVie’s Humira (adalimumab). The decision allows Yuflyma to be ...